Download video

How to -PREVENT- Pharma Sales Objections

29 views

Finding Pharma

1 year ago

How to -PREVENT- Pharma Sales Objections

How to -PREVENT- Pharma Sales Objections

Potency and efficacy of PIP4K2 inhibitors in ALL: looking forward to first-in-human trials
0:52
Potency and efficacy of PIP4K2 inhibitors in ALL: looking forward to first-in-human trials
by VJHemOnc – Video Journal of Hematology \& HemOnc
CPIC guideline for serotonin reuptake inhibitors and CYP2D6, HTR2A and SLC6A4 - no recommendations
3:34
CPIC guideline for serotonin reuptake inhibitors and CYP2D6, HTR2A and SLC6A4 - no recommendations
by PharmGKB
Assay and Related Substances RS
8:53
Assay and Related Substances RS
by Pharma Learning In Depth
Dose Proportional Formulation
4:20
Dose Proportional Formulation
by Pharma Learning In Depth
Interim analysis of a Phase II study of pirtobrutinib + venetoclax in previously treated WM
2:25
Interim analysis of a Phase II study of pirtobrutinib + venetoclax in previously treated WM
by VJHemOnc – Video Journal of Hematology \& HemOnc
Potency and Purity
5:24
Potency and Purity
by Pharma Learning In Depth
PBRER Section 2 to 4
2:02:35
PBRER Section 2 to 4
by PharmaIdiots
Twogap Solution Mechanism
0:24
Twogap Solution Mechanism
by Bac Nam Hoang
Q1 Q2 Q3 De-formulation \& Equivalence
5:55
Q1 Q2 Q3 De-formulation \& Equivalence
by Pharma Learning In Depth
CPIC guideline for citalopram, escitalopram and CYP2C19
9:49
CPIC guideline for citalopram, escitalopram and CYP2C19
by PharmGKB
Gastritis heilen Beseitige deine Gastritis schnell und natürlich - Einfaches Heilmittel
4:46
Gastritis heilen Beseitige deine Gastritis schnell und natürlich - Einfaches Heilmittel
by Gesundheitsblatt
Portal Hypertension: Animated Review
7:45
Portal Hypertension: Animated Review
by FSUMedMedia
Final results of a Phase II study of add-on parsaclisib for pts with MF and suboptimal rux response
1:07
Final results of a Phase II study of add-on parsaclisib for pts with MF and suboptimal rux response
by VJHemOnc – Video Journal of Hematology \& HemOnc
2-2 The Business of our Business
57:25
2-2 The Business of our Business
by P2P RETAC
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
58:39
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
by Fit Rx Health + Wellness
340B Rebate Model Part 2: Turning Policy into Practice
58:46
340B Rebate Model Part 2: Turning Policy into Practice
by PharmaForce
Alpha-2 Antiplasmin
7:04
Alpha-2 Antiplasmin
by Medicosis Perfectionalis
Forced Degradation Study as per ICH Q1AR2 The Science Behind Stability
9:45
Forced Degradation Study as per ICH Q1AR2 The Science Behind Stability
by ResolveMass Laboratories Inc.
P2Y12 Receptor Inhibitors
18:07
P2Y12 Receptor Inhibitors
by Medicosis Perfectionalis
Part 2: How pharma is using M\&A for growth and innovation
3:02
Part 2: How pharma is using M\&A for growth and innovation
by Parexel International
Chapter 2: Factors Influencing Substance Use
8:14
Chapter 2: Factors Influencing Substance Use
by Brockton Area Prevention Collaborative
DOACs Part 2: Anticoagulation Principles - Part 2: Kinetics, Drug Interactions, and Precautions
17:18
DOACs Part 2: Anticoagulation Principles - Part 2: Kinetics, Drug Interactions, and Precautions
by The PharmEZ Tutor
Pharmacology of pertuzumab (Perjeta) ; Mechanism of action, Pharmacokinetics, Uses, Effects
2:05
Pharmacology of pertuzumab (Perjeta) ; Mechanism of action, Pharmacokinetics, Uses, Effects
by MBBS NAIJA